Technology in Cancer Research & Treatment (Sep 2021)

MiR-9-1 Suppresses Cell Proliferation and Promotes Apoptosis by Targeting UHRF1 in Lung Cancer

  • Cheng-You Jia PhD,
  • Wei Xiang PhD,
  • Ji-Bin Liu MD,
  • Geng-Xi Jiang MD,
  • Feng Sun MD,
  • Jian-Jun Wu MD,
  • Xiao-Li Yang PhD,
  • Rui Xin PhD,
  • Yi Shi PhD,
  • Dan-Dan Zhang PhD,
  • Wen Li PhD,
  • Zavuga Zuberi PhD,
  • Jie Zhang PhD,
  • Gai-Xia Lu MD,
  • Hui-Min Wang PhD,
  • Pei-Yao Wang PhD,
  • Fei Yu MD,
  • Zhong-Wei Lv MD,
  • Yu-Shui Ma PhD,
  • Da Fu PhD

DOI
https://doi.org/10.1177/15330338211041191
Journal volume & issue
Vol. 20

Abstract

Read online

Lung cancer is listed as the most common reason for cancer-related death all over the world despite diagnostic improvements and the development of chemotherapy and targeted therapies. MicroRNAs control both physiological and pathological processes including development and cancer. A microRNA-9 to 1 (miR-9 to 1) overexpression model in lung cancer cell lines was established and miR-9 to 1 was found to significantly suppress the proliferation rate in lung cancer cell lines, colony formation in vitro, and tumorigenicity in nude mice of A549 cells. Ubiquitin-like containing PHD and RING finger domains 1 (UHRF1) was then identified to direct target of miR-9 to 1. The inhibition of UHRF1 by miR-9 to 1 causes G1 arrest and p15, p16, and p21 were re-expressed in miR-9 to 1 group in mRNA level and protein level. Silence of UHRF1 expression in A549 cells resulted in the similar re-expression of p15, p16, p21 which is similar with miR-9 to 1 infection. Therefore, we concluded that UHRF1 is a new target for miR-9 to 1 to suppress cell proliferation by re-expression of tumor suppressors p15, p16, and p21 mediated by UHRF1.